U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647991) titled 'The IGBallon (R) - for Use in the Treatment of Obesity' on May 20.
Brief Summary: This study is a prospective, non-randomized, open-label, single-center study.
The aim of this study is to assess the safety of the IGballoon in the human body. The effectiveness of the IGBalloon in relation to weight loss behaviour of the human body will also be investigated. This study will involve 20 participants who will be divided into two groups:
1. Monitoring group with 5 participants who swallow an IGBalloon. After four weeks, safety will be tested. Up to four additional IGBalloons may be ingested, if necessary, over the following eight weeks....